Mutations of BRAF and BIRC3 Identify a Subgroup of Chronic Lymphocytic Leukemia with Very Poor Prognosis upon FCR Treatment

被引:0
|
作者
Moia, Riccardo [1 ]
Diop, Fary [1 ]
Favini, Chiara [1 ]
Spaccarotella, Elisa [1 ]
De Paoli, Lorenzo [1 ]
Bruscaggin, Alessio [2 ]
Spina, Valeria [2 ]
Cerri, Michaela
Deambrogi, Clara [1 ]
Kodipad, Ahad Ahmed [1 ]
Favini, Simone [1 ]
Sagiraju, Sruthi [1 ]
Jabangwe, Clive [1 ]
Mauro, Francesca Romana [3 ]
Del Giudice, Ilaria [3 ]
Forconi, Francesco [4 ,5 ,6 ]
Cortelezzi, Agostino [7 ,8 ]
Zaja, Francesco [9 ]
Visco, Carlo [10 ]
Chiarenza, Annalisa [11 ]
Rigolin, Gian Matteo [12 ]
Marasca, Roberto [13 ]
Coscia, Marta [14 ,15 ]
Perbellini, Omar [16 ]
Tedeschi, Alessandra [17 ]
Laurenti, Luca [18 ]
Motta, Marina [19 ]
Del Poeta, Giovanni [20 ]
Cuneo, Antonio [12 ]
Gattei, Valter [21 ]
Foa, Robin [3 ]
Gaidano, Gianluca [1 ]
Rossi, Davide [2 ]
机构
[1] Amedeo Avogadro Univ Eastern Piedmont, Dept Translat Med, Div Hematol, Novara, Italy
[2] Inst Southern Switzerland, Inst Oncol Res & Oncol, Bellinzona, Switzerland
[3] Sapienza Univ, Dept Cellular Biotechnol & Hematol, Hematol, Rome, Italy
[4] Univ Southampton, Southampton Canc Res UK, Canc Sci Unit, Southampton, Hants, England
[5] Univ Southampton, Natl Inst Hlth Res, Expt Canc Med Ctr, Southampton, Hants, England
[6] Univ Siena, Div Hematol, Siena, Italy
[7] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Hematol Oncol, Milan, Italy
[8] Univ Milan, Milan, Italy
[9] Univ Udine, DAME, Clin Ematol, Udine, Italy
[10] Osped San Bortolo, Dept Cell Therapy & Hematol, Vicenza, Italy
[11] Azienda Osped Univ Policlin OVE, Div Hematol, Catania, Italy
[12] Univ Ferrara, Azienda Osped Univ Arcispedale S Anna, Hematol Sect, Ferrara, Italy
[13] Univ Modena & Reggio Emilia, Dept Hematol & Oncol, Div Hematol, Modena, Italy
[14] Azienda Ospedaliero Univ Citta Salute & Sci, Div Hematol, Turin, Italy
[15] Univ Turin, Turin, Italy
[16] Univ Verona, Dept Med, Sect Hematol, Verona, Italy
[17] Osped Niguarda Ca Granda, Niguarda Canc Ctr, Dept Oncol Haematol, Milan, Italy
[18] Univ Cattolica Sacro Cuore, Inst Hematol, Rome, Italy
[19] Spedali Civil Brescia, Dept Hematol, Brescia, Italy
[20] Tor Vergata Univ, Dept Hematol, Rome, Italy
[21] IRCCS, Ctr Riferimento Oncol, Clin & Expt Oncohematol Unit, Aviano, Italy
来源
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷 / 10期
关键词
chronic lymphocytic leukemia; FCR; immunochemotherapy; molecular predictors; precision medicine;
D O I
10.1016/j.clml.2017.09.039
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CLL-009
引用
收藏
页码:S11 / S12
页数:2
相关论文
共 50 条
  • [21] Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia
    Nadeu, Ferran
    Delgado, Julio
    Royo, Cristina
    Baumann, Tycho
    Stankovic, Tatjana
    Pinyol, Magda
    Jares, Pedro
    Navarro, Alba
    Martin-Garcia, David
    Bea, Silvia
    Salaverria, Itziar
    Oldreive, Ceri
    Aymerich, Marta
    Suarez-Cisneros, Helena
    Rozman, Maria
    Villamor, Neus
    Colomer, Dolors
    Lopez-Guillermo, Armando
    Gonzalez, Marcos
    Alcoceba, Miguel
    Jose Terol, Maria
    Colado, Enrique
    Puente, Xose S.
    Lopez-Otin, Carlos
    Enjuanes, Anna
    Campo, Elias
    BLOOD, 2016, 127 (17) : 2122 - 2130
  • [22] Perspectives on Precision Medicine in Chronic Lymphocytic Leukemia: Targeting Recurrent Mutations-NOTCH1, SF3B1, MYD88, BIRC3
    Putowski, Maciej
    Giannopoulos, Krzysztof
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (16)
  • [23] Somatic MED12 mutations are associated with poor prognosis markers in chronic lymphocytic leukemia
    Kampjarvi, Kati
    Jaervinen, Tiina M.
    Heikkinen, Tuomas
    Ruppert, Amy S.
    Senter, Leigha
    Hoag, Kevin W.
    Dufva, Olli
    Kontro, Mika
    Rassenti, Laura
    Hertlein, Erin
    Kipps, Thomas J.
    Porkka, Kimmo
    Byrd, John C.
    de la Chapelle, Albert
    Vahteristo, Pia
    ONCOTARGET, 2015, 6 (03) : 1884 - 1888
  • [24] COPY NUMBER ANALYSIS OF THE BIRC3 GENE BY DROPLET DIGITAL PCR IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH 11Q DELETION
    Raponi, S.
    Del Giudice, I.
    Ilari, C.
    Cafforio, L.
    Piciocchi, A.
    Marinelli, M.
    Messina, M.
    Mauro, F. R.
    Rigolin, G. M.
    Rossi, F.
    Dal Bo, M.
    Cuneo, A.
    Gaidano, G.
    Gattei, V.
    Guarini, A.
    Foa, R.
    HAEMATOLOGICA, 2016, 101 : 223 - 224
  • [25] NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment
    Chiaretti, Sabina
    Marinelli, Marilisa
    Del Giudice, Ilaria
    Bonina, Silvia
    Piciocchi, Alfonso
    Messina, Monica
    Vignetti, Marco
    Rossi, Davide
    Di Maio, Valeria
    Mauro, Francesca Romana
    Guarini, Anna
    Gaidano, Gianluca
    Foa, Robin
    LEUKEMIA & LYMPHOMA, 2014, 55 (12) : 2785 - 2792
  • [26] Low T3 syndrome as a predictor of poor prognosis in chronic lymphocytic leukemia
    Gao, Rui
    Chen, Rui-Ze
    Xia, Yi
    Liang, Jin-Hua
    Wang, Li
    Zhu, Hua-Yuan
    Wu, Jia-Zhu
    Fan, Lei
    Li, Jian-Yong
    Yang, Tao
    Xu, Wei
    INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (03) : 466 - 477
  • [27] Postremissional rituximab administration for the treatment of poor prognosis chronic lymphocytic leukemia (CLL) patients.
    Mauro, FR
    Gentile, M
    Alimena, G
    De Propris, S
    Cimino, G
    Giammartini, E
    Buffolino, S
    Mandelli, F
    Foa, R
    BLOOD, 2002, 100 (11) : 361B - 361B
  • [28] Variant t(9;22) translocation may identify a subgroup of chronic myeloid leukemia patients with poor prognosis.
    Albano, F
    Specchia, G
    Pannunzio, A
    Roberti, MG
    Buquicchio, C
    Mestice, A
    Greco, G
    Liso, V
    BLOOD, 2001, 98 (11) : 321A - 321A
  • [29] Frequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with Europeans
    Xia, Yi
    Fan, Lei
    Wang, Li
    Gale, Robert Peter
    Wang, Man
    Tian, Tian
    Wu, Wei
    Yu, Liang
    Chen, Yao-Yu
    Xu, Wei
    Li, Jian-Yong
    ONCOTARGET, 2015, 6 (07) : 5426 - 5434
  • [30] HIGH RISK CYTOGENETICS, ELEVATED LDH AND ISS-3 IDENTIFY A SUBGROUP OF MYELOMA PATIENTS WITH VERY POOR PROGNOSIS
    Kastritis, E.
    Terpos, E.
    Roussou, M.
    Gavriatopoulou, M.
    Iakovaki, M.
    Kalapanida, D.
    Kanellias, N.
    Eleutherakis-Papaiakovou, E.
    Gika, D.
    Dimopoulos, M.
    HAEMATOLOGICA, 2013, 98 : 334 - 334